Le Lézard
Classified in: Transportation, Health
Subjects: AWD, NPT, CHI, CSR

Hyundai Hope On Wheels Presents The Georgetown Lombardi Comprehensive Cancer Center With $100,000 Hyundai Impact Award To Support Pediatric Cancer Research


WASHINGTON, July 6, 2018 /PRNewswire/ -- Hyundai Hope On Wheels® 501c3 nonprofit organization, celebrates its 20th year funding pediatric cancer research and will present Dr. Jeffrey Toretsky of Georgetown Lombardi Comprehensive Cancer Center with a $100,000 Hyundai Impact Award. This institution is one of 21 recipients of this year's award, which is given to pediatric oncology departments at select medical centers nationwide. The $100,000 Hyundai Impact Award will be officially presented to Dr. Jeffrey Toretsky and Georgetown Lombardi on Tuesday, July 10th at 10:00 a.m.

Hyundai Hope On Wheels Logo (PRNewsfoto/Hyundai Hope On Wheels)

In 2018, Hope On Wheels will award over $15 million toward pediatric cancer research and programs. This brings the organization's donation total to $145 million since Hyundai joined the fight against pediatric cancer 20 years ago in 1998. With this latest grant, the Georgetown Lombardi Comprehensive Cancer Center has received more than  $1.6 million from Hope On Wheels.

"Throughout the country, talented doctors are working tirelessly to help kids fight cancer by conducting research or providing bedside care," said Scott Fink, chairman, Hyundai Hope On Wheels Board of Directors. "Our goal at Hope On Wheels is to provide these doctors with the grant funds they need to perform their lifesaving work."

During the event, children who are battling cancer at Georgetown Lombardi will participate in the program's signature Handprint Ceremony, in which they'll dip their hands in paint and place their handprints on a white 2018 Hyundai Santa Fe. Their colorful handprints on the official Hope Vehicle represent their individual and collective journeys, hopes and dreams.

For more information about Hyundai Hope On Wheels and to view a complete list of this year's grant winners, please visit HyundaiHopeOnWheels.org/research . Follow us on Facebook, Twitter or Instagram at facebook.com/HyundaiHopeOnWheels, twitter.com/HopeOnWheels or instagram.com/HyundaiHopeOnWheels

HYUNDAI HOPE ON WHEELS
Hyundai Hope On Wheels® is a 501(c)(3) non-profit organization that is committed to finding a cure for childhood cancer. Launched in 1998, Hyundai Hope On Wheels provides grants to eligible institutions nationwide that are pursuing life-saving research and innovative treatments for the disease. HHOW is one of the largest non-profit funders of pediatric cancer research in the country, and primary funding for Hyundai Hope On Wheels comes from Hyundai Motor America and its more than 835 U.S. dealers. Since its inception, Hyundai Hope On Wheels has awarded more than $145 million towards childhood cancer research in pursuit of a cure.

HYUNDAI MOTOR AMERICA
Hyundai Motor America, headquartered in Fountain Valley, Calif., is a subsidiary of Hyundai Motor Company of Korea. Hyundai vehicles are distributed throughout the United States by Hyundai Motor America and are sold and serviced through 835 dealerships nationwide. All new Hyundai vehicles sold in the U.S. are covered by the Hyundai Assurance program, which includes a 5-year/60,000-mile fully-transferable new vehicle limited warranty, Hyundai's 10-year/100,000-mile powertrain limited warranty and five years of complimentary Roadside Assistance.

For more details on Hyundai Assurance, please visit www.HyundaiAssurance.com
Please visit our media website at www.hyundainews.com
Hyundai Motor America on Twitter | YouTube | Facebook

 

SOURCE Hyundai Hope On Wheels


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: